Skip to content

Pregnancy and Omega-3 supplements

A clinical Trial on effect of omega-3 Fatty acids on pregnancy outcome

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT138811173291N1
Enrollment
120
Registered
2010-06-03
Start date
2006-09-30
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pregnancy.

Interventions

Intervention 1: Fish oil (omega 3) Salmon, 1000 mg capsules, oral, once a day, since 16th gestational week until the end of pregnancy as well as routine prenatal care. Intervention 2: routine prenatal
Fish oil (omega 3) Salmon, 1000 mg capsules, oral, once a day, since 16th gestational week until the end of pregnancy as well as routine prenatal care

Sponsors

Arak University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria: age 18 to 40 years, single pregnancy, the first visit before 16 weeks of pregnancy, weight before 16 weeks gestation 45 kg or more, and 4 or less parities . Exclusion criteria: low or noncompliance, irregular visit, current gestational diabetes, fetal defects, delivery at home or outside the city of Arak

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Neonate's Birth weight. Timepoint: at birth. Method of measurement: in grams.;Neonates height. Timepoint: at birth. Method of measurement: in centimeters.;Neonate's head circumference. Timepoint: at birth. Method of measurement: in centimeters.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasoumeh Davoodabadi Farahani

Arak University of Medical Sciences

ma_davoodi@hotmail.comma.davoodi@yahoo.comdavoodabadi.m@arakmu.ac.ir+98 86 1417 3502

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026